Clinical trial

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

NCT05335044

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-05-31

PhasePHASE1

Study timeline

Study start (actual)2022-05-31Date precision: day

Registry last updated2023-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension and Dyslipidemiaunresolved

Interventions

CKD-331DRUG

EX5619DRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05335044 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.